PDS Biotechnology Corporation Awarded $1.28M National Cancer Institute Contract

The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.

Related Posts

Comments are closed.